Prosus took part in a $63m round for logistics service provider Shipper while V1 Group-backed animation platform developer Laihua raised over $25m.

The home fitness equipment provider's third round in six months was co-led by Legend Capital and also featured Bertelsmann Asia Investments, Tencent and Nio Capital.

Longfor Group, Tencent and Meituan Dianping were among the investors to back the cleaning robot producer’s series B-plus round.

UTEC has returned to co-lead a $14m funding round for ImmunoScape, which will use the money to bolster its presence in Singapore and the US.

IU Ventures has returned for a series B round for Encamp, having previously taken part in a series A round year.

Asahi Kasei Ventures took part in a $70m round for food waste technology provider Hazel Technologies while Zoll Medical Corporation bought portfolio company Respicardia.

ECBF has supplied an extension to Aphea.Bio’s series B round, which already included Gemma Frisius Fund, Qbic, Vives and V-Bio Ventures.

Vision Fund 2 participated in a series B round for the gene therapy developer, formed through the 2019 merger of Torque Therapeutics and Cogen Immune Medicine.

Vizgen co-founder David Walt, a professor at Harvard Medical School, has invested in the spinout as part of its series B round.

Gene therapy developer Jaguar has completed a series B round co-led by Eli Lilly and Deerfield Management.